Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PELICAN: Topical vs Systemic Treatment for Localized Neuropathic Pain
NCT03348735Phase 4Terminated
- Start
- Dec 2018
- Primary completion
- Apr 2021
- Modality
- Transdermal Patches, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of lidocaine 10% oropharyngeal spray, capsaicin 8% patch in neuropathic pain. Started Dec 2018; status: terminated.
02
Drugs
lidocaine 10% oropharyngeal spraycapsaicin 8% patch
03
Conditions
neuropathic pain
Beyond the preview
Go deeper on NCT03348735.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03348735.